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IL-10 is an important immune-regulatory cyto-
kine (Moore et al., 2001), and IL-10 produced by   
T cells is important for the prevention of auto-
immune disease and immunopathology upon 
chronic infections (Groux et al., 1997; Asseman   
et al., 1999; Roers et al., 2004; Anderson et al.,   
2007; Jankovic et al., 2007; Couper et al., 
2008). Two main subsets of IL-10–producing 
T cells with immune-regulatory functions have 
been described: “natural” and “adaptive” T reg 
cells (Bluestone and Abbas, 2003). Both subsets 
have been shown to prevent autoimmune dis-
eases and limit immune responses (Groux et al., 
1997;  Roncarolo  and  Levings,  2000;  Maloy 
and Powrie, 2001; Vieira et al., 2004), and lack 
IL-2–producing capacities (Groux et al., 1997; 
Sakaguchi, 2004; Vieira et al., 2004; Scheffold 
et al., 2005). They can be generated from naive 
T cells following different protocols of tolero-
genic  priming  (Groux et al., 1997; Seddon 
and Mason, 1999; Jonuleit et al., 2000; Walker   
et al., 2003; Apostolou and von Boehmer, 2004),   
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Interleukin (IL)-10 produced by regulatory T cell subsets is important for the prevention 
of autoimmunity and immunopathology, but little is known about the phenotype and 
function of IL-10–producing memory T cells. Human CD4+CCR6+ memory T cells contained 
comparable numbers of IL-17– and IL-10–producing cells, and CCR6 was induced under 
both Th17-promoting conditions and upon tolerogenic T cell priming with transforming 
growth factor (TGF)–. In normal human spleens, the majority of CCR6+ memory T cells 
were in the close vicinity of CCR6+ myeloid dendritic cells (mDCs), and strikingly, some of 
them were secreting IL-10 in situ. Furthermore, CCR6+ memory T cells produced suppres-
sive IL-10 but not IL-2 upon stimulation with autologous immature mDCs ex vivo, and 
secreted IL-10 efficiently in response to suboptimal T cell receptor (TCR) stimulation with 
anti-CD3 antibodies. However, optimal TCR stimulation of CCR6+ T cells induced expression 
of IL-2, interferon-, CCL20, and CD40L, and autoreactive CCR6+ T cell lines responded 
to various recall antigens. Notably, we isolated autoreactive CCR6+ T cell clones with 
context-dependent behavior that produced IL-10 with autologous mDCs alone, but that 
secreted IL-2 and proliferated upon stimulation with tetanus toxoid. We propose the 
novel concept that a population of memory T cells, which is fully equipped to participate 
in secondary immune responses upon recognition of a relevant recall antigen, contributes 
to the maintenance of tolerance under steady-state conditions.
© 2010 Rivino et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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constitutively in lymphoid and nonlymphoid tissues and   
up-regulated upon inflammation, but the CCR6–CCL20 
axis appears to be particularly important for migration of 
immune cells to the gut and the skin (Cook et al., 2000; 
Schutyser et al., 2003). Studies on CCR6-deficient mice 
  indicated a nonredundant role for CCR6 in gut lymphoid 
tissue homeostasis (Cook et al., 2000; Varona et al., 2001). 
Furthermore,  CCR6-deficient  mice  have  altered  CD4+  
T cell responses, including reduced contact hypersensitiv-
ity  and  enhanced  delayed  type  hypersensitivity  responses 
  (Lukacs et al., 2001; Varona et al., 2001, 2005). CCL20 and 
CCR6 are further involved in several autoimmune diseases 
including  psoriasis  (Homey  et  al.,  2000),  inflammatory 
bowel disease (Varona et al., 2003; Kaser et al., 2004), ex-
perimental autoimmune encephalomyelitis (Kleinewietfeld 
et al., 2005), and rheumatoid arthritis (Matsui et al., 2001; 
Ruth et al., 2003). Furthermore, we and others have shown 
that CCR6 is expressed on human Th17 cells (Acosta-
  Rodriguez et al., 2007; Annunziato et al., 2007).
In this paper, we show that CCR6+ human memory   
T cells have a low stimulation threshold for IL-10 production 
and, consequently, secrete IL-10 after suboptimal stimulation 
by autologous DCs ex vivo and in the spleen in situ. These 
autoreactive memory T cells are distinct from the effector-
like cells with regulatory activity that we identified previously 
(Häringer et al., 2009). They produce IL-2 and IFN-, and 
proliferate  after  strong  stimulation  with  recall  antigens, 
  suggesting that they can have a context-dependent function 
depending on the strength of TCR stimulation.
RESULTS
TGF- promotes CCR6 expression on primed human  
CD4+ T cells
The chemokine receptor CCR6 is expressed on Th17 and 
T reg cells (Kleinewietfeld et al., 2005; Acosta-Rodriguez   
et al., 2007; Annunziato et al., 2007). We observed that   
TGF- promoted CCR6 expression after naive (CD45RA+   
  CCR7+CCR6CD25) human CD4+ T cell priming with 
anti-CD3 and anti-CD28 antibodies (Fig. 1 a) or allogenic 
DCs (not depicted). Naive T cells were labeled with CFSE for 
these experiments to exclude undivided cells from the analy-
sis. TGF-–dependent CCR6 expression was inhibited by the   
Th1- or Th2-polarizing cytokines IL-4 or IL-12 but not   
by IL-10. IL-4 was highly efficient in preventing CCR6 ex-
pression, because it completely prevented TGF-–dependent 
CCR6 induction (in six different donors in independent ex-
periments from 22 ± 12 to 2 ± 2%; P < 0.05), whereas IL-12   
also  reduced  the  mean  CCR6  expression  significantly  but 
less efficiently (to 10 ± 4%). Consistent with previous results 
(Acosta-Rodriguez et al., 2007), the proinflammatory cyto-
kines TNF, IL-1, and IL-6 also promoted CCR6 expres-
sion and synergized with TGF-, indicating that CCR6 can 
be  induced  under  either  tolerogenic  or  Th17-promoting 
conditions. In the absence of polarizing or proinflammatory 
cytokines, TGF- promoted FOXP3 expression as expected 
(Fantini et al., 2004), but a fraction of CCR6+ cells remained 
and TGF- is required for IL-10 production from both subsets 
in vivo (Maynard et al., 2007). Natural T reg cells have been 
characterized in detail both in mice and humans. Thus, nat-
ural T reg cells can already mature in the thymus and express 
CD25, the high affinity receptor for IL-2, (Shevach, 2001; 
Sakaguchi,  2004),  and  the  transcription  factor  FOXP3   
(Sakaguchi, 2004). The maintenance and function of natural 
CD25+ T reg cells relies on IL-2 that is produced by activated 
Th cells (Scheffold et al., 2005), consistent with the autoim-
mune phenotype of IL-2–deficient mice. However, IL-2 also 
has some immunostimulatory effects, which might be induced 
at higher levels of IL-2 production (Scheffold et al., 2005), 
because it can promote memory T cell generation (Dooms   
et al., 2007) and autoimmunity (Waithman et al., 2008). Less 
is known about adaptive T reg cells because their phenotype 
and characteristics vary between different experimental set-
tings. However, we have recently identified CD4+FOXP3 
effector-like cells in human blood that coproduce IL-10 and 
IFN- and suppress T cell activation via IL-10 (Häringer   
et al., 2009). Notably, these Tr1-like cells are distinct from 
memory cells, because they are activated in vivo, have lost 
IL-7R expression, produce little IL-2, and do not respond 
to vaccination antigens.
The strength of TCR stimulation depends on the avidity 
of the TCR/peptide–MHC interaction and on engagement of   
co-stimulatory  receptors,  and  is  an  important  parameter   
of T cell activation to discriminate between tolerance and 
  immunity (Lanzavecchia and Sallusto, 2002). In the thymus, 
developing T cells with a low affinity for self-MHC mole-
cules are selected for survival (van den Boorn et al., 2006), 
whereas those with a higher affinity for self-peptides become 
CD25+ T reg cells (Jordan et al., 2001). In the periphery, 
low-level TCR stimulation of mature naive T cells by self-
MHC is essential for their survival and antigen responsive-
ness in the mouse (Brocker, 1997; Stefanová et al., 2002). 
Importantly,  this  TCR  “tickling”  by  self-MHC  is  also 
  important for mouse CD4+ memory T cells, because they 
become nonfunctional upon transfer into MHC class II–
  deficient hosts (Kassiotis et al., 2002). However, suboptimal 
TCR stimulation in the absence of co-stimulation can also 
induce a state of unresponsiveness called anergy in T cells 
(Schwartz, 1997), or lead to a state of unfitness and abortive 
proliferation in both mouse and human T cells (Gett et al., 
2003). The strength of TCR stimulation also regulates dif-
ferent  functional  responses,  because  clones  derived  from 
  human CD8+ memory T cells have different stimulation 
thresholds for cytotoxicity, IFN- production, and prolifer-
ation (Valitutti et al., 1996). In the case of CD4+ T cells, it 
was shown that IL-2 and IL-10 are preferentially induced by 
different  co-stimulatory  receptors  (Hutloff  et  al.,  1999; 
Blair et al., 2000), but whether the secretion of these two 
key cytokines is differentially regulated by the strength of 
TCR stimulation has not been investigated.
CCR6 is a chemokine receptor expressed on B cells, a 
fraction  of  T  cells,  and  immature  DCs  (Schutyser  et  al., 
2003). The ligand of CCR6, CCL20, is widely expressed JEM VOL. 207, March 15, 2010 
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Low stimulation threshold for IL-10 production  
in CCR6+ memory T cells
Human memory T cells have different activation thresholds 
for the expression of activation-induced surface receptors. 
Thus, total memory cells could be efficiently activated by 
suboptimal stimulation with anti-CD3 antibodies to ex-
press the CD69 activation marker but required CD28 co-
  stimulation for the up-regulation of CD40L (Fig. 2 a). Also, 
the induction of cytokines had different stimulation thresh-
olds. Thus, memory T cells secreted IL-10 efficiently at late 
time points with anti-CD3 antibodies alone, whereas IL-2 
secretion and optimal IFN- production occurred earlier 
and required CD28 co-stimulation (Fig. 2 b).
We previously showed that CCR6 is expressed on human 
blood Th17 cells but not on Th2 cells, whereas IL-2– and 
IFN-–producing cells are present among both CCR6+  
and CCR6 T cells (not depicted; Acosta-Rodriguez et al.,   
2007). We investigated the IL-10–producing capacities of   
CCR6+ and CCR6 memory T cells in response to anti-CD3 
FOXP3, showing that cells that acquire CCR6 upon tolero-
genic priming do not necessarily become FOXP3+ T reg cells. 
Consistently, as shown in Fig. 1 b, CCR6 in human blood 
was found not only on the majority of FOXP3+ T reg cells 
but also on a large fraction of CD25FOXP3 memory cells,   
whereas phenotypic naive cells were largely CCR6. Vir-
tually all (99%) CD25CCR6+ cells expressed the memory 
marker IL-7R, but they were heterogeneous for CCR7, 
integrin  7,  and  cutaneous  lymphocyte-associated  antigen 
(CLA), indicating that they contained central memory T, ef-
fector memory T, and gut- and skin-homing cells (Fig. 1 c).   
A similar heterogeneity was observed among CCR6 cells   
for all analyzed surface markers with the exception of the 
integrin  E  subunit  (also  regulated  by  TGF-;  Hadley   
et al., 1997), which was selectively expressed on a small fraction 
of CCR6+ cells (Fig. 1 c). Collectively, these results suggest   
that CCR6 is expressed on antigen-experienced T cells that 
could have been primed under either tolerogenic or Th17-
promoting conditions.
Figure 1.  CCR6 is induced by TGF- and expressed on populations of CD25+ T reg cells and CD4+ memory T cells. (a) CFSE-labeled peripheral 
blood naive CD4+ T cells were stimulated with anti-CD3 and anti-CD28 antibodies for 4 d in the presence or absence of the indicated cytokines. Cells 
were stained at day 5, and CFSE cells were analyzed for CCR6 and FOXP3 expression by flow cytometry. (b) Peripheral blood CD4+ T cell populations 
were analyzed for CCR6 and FOXP3 expression by flow cytometry ex vivo. Numbers indicate percentages. (c) Peripheral blood CD4+CD45RACD25 
memory T cells were stained with antibodies specific for CCR6, IL-7R, CCR7, CLA, CXCR5, and integrin 7 and E, and were analyzed by flow cytometry. 
The mean percentage of CCR6+ or CCR6 cells expressing the relevant surface marker of three different donors is shown.568 Context-dependent memory T cells | Rivino et al.
CD3 antibodies alone (4.3 ± 2.6 vs. 0.7 ± 0.4%; P < 0.05; 
Fig. 2 c). Similar results were obtained by analyzing superna-
tants of stimulated cells by ELISA (unpublished data). The 
fraction of CCR6+ T cells producing IL-10 with anti-CD3 
was relatively small, but it was similar to the fraction of Th17 
cells (4.6 ± 2.8% of IL-17A+ cells upon CD28 co-stimulation;   
Fig. 2 c). Conversely, a major fraction of CCR6+ T cells pos-
sessed CCL20-producing capacities, including not only vir-
tually all Th17 cells, as expected, but also many IL-10–secreting   
antibodies in the absence or presence of CD28 co-stimulation. 
Because IL-7R is a memory cell marker and IL-7R cells are 
effector-like  cells  with  high  IL-10–producing  capacities 
(Häringer et al., 2009), we also purified CCR6+ and CCR6 
memory T cell populations according to IL-7R expression. 
Interestingly, although variable fractions of both CCR6+ and 
CCR6 memory T cells produced IL-10 in response to anti-
CD3 in the presence of CD28 co-stimulation, only CCR6+ 
T cells secreted IL-10 efficiently upon stimulation with anti-
Figure 2.  Ex vivo cytokine production of CCR6+ and CCR6 memory T cells after weak or strong TCR stimulation. (a) Up-regulation of CD69 
and CD40L after stimulation of total antigen-experienced Th cells (CD45RACD25) with anti-CD3 alone (left) or anti-CD3 plus anti-CD28 (right). One 
experiment out of three is shown. (b) Production of IL-10 versus IL-2 (left) or versus IFN- (right) at 6 (top) and 30 (bottom) h after stimulation with anti-
CD3 alone or anti-CD3 plus anti-CD28. One representative experiment out of eight is shown. (c) Expression of CCL20 and IL-10 (left) or IL-17 (right) of 
CCR6+ and CCR6 memory T cells (IL-7R+CD25CD45RA) after stimulation with anti-CD3 antibodies in the absence or presence of CD28 co-stimulation. 
Two representative donors out of six analyzed in three independent experiments are shown. Numbers indicate percentages.JEM VOL. 207, March 15, 2010 
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proliferate  or  secrete  cytokines  in  response  to  autologous 
DCs. We used circulating DCs isolated ex vivo, because in 
healthy subjects they could present self-antigens as well as 
physiologically relevant innocuous foreign antigens that they 
are exposed to in the steady state. Allogenic DCs were used 
in parallel as a positive control. CFSE-labeled CCR6+ and 
CCR6 T cells proliferated vigorously with allogenic DCs, as 
expected, but weakly (CCR6+) or not at all (CCR6) with 
autologous DCs (Fig. 3 a). However, CCR6+ but not CCR6 
memory T cells proliferated vigorously with autologous   
DCs when neutralizing anti–IL-10 antibodies were added, 
whereas  an  isotype-matched  control  antibody  had  no 
cells  (Fig.  2  c)  that  lack  IL-17–producing  capacities  (not 
  depicted; Häringer et al., 2009). Thus, unlike CCR6 mem-
ory T cells, CCR6+ cells could attract other CCR6+ cells via 
CCL20  and  secrete  IL-10  efficiently  upon  weak  TCR 
  stimulation. Conversely, both CCR6+ and CCR6 mem-
ory cells produce CD40L, IL-2, IL-10, and IFN- after 
  optimal activation.
CCR6+ T cells produce suppressive IL-10 upon contact  
with autologous DCs
We  then  analyzed  whether  memory  T  cell  populations 
  differed in autoreactivity, which we defined as the capacity to 
Figure 3.  CCR6+ memory T cells proliferate with autologous DCs upon IL-10 neutralization. (a) Purified CCR6+ and CCR6 T cells were incubated 
with ex vivo–isolated autologous or allogenic mDCs in the presence or absence of neutralizing anti–IL-10 antibodies. On day 7, CFSE profiles of T cells 
were analyzed by flow cytometry. One experiment out of six is shown. Numbers indicate percentages. (b) CCR6+ T cells and autologous mDCs were puri-
fied after 24 h following co-culture or culture in medium alone. IL-10 mRNA levels relative to 18S rRNA were quantified by quantitative real-time RT-PCR. 
Results are expressed in arbitrary units (AU) of IL-10 mRNA/18S rRNA. Error bars represent means of three different experiments analyzing different do-
nors. (c) CCR6+ T cells were co-cultured with autologous or allogenic mDCs, and culture supernatants were assessed by ELISA for the presence of IL-2 and 
IL-10. The mean of three independent experiments is shown.570 Context-dependent memory T cells | Rivino et al.
  proliferation via IL-10 was limited to conditions of weak 
TCR stimulation and limited IL-2 availability. Consistently, 
addition of exogenous IL-2 to autologous cultures induced 
vigorous CCR6+ T cell proliferation in the absence of IL-10 
neutralization, and CCR6 T cells also proliferated under this 
condition, but to a lower extent (unpublished data). In sum-
mary, these findings indicate that autologous DCs provide 
a suboptimal TCR stimulation of CCR6+ T cells, which is 
sufficient for IL-10 production that, in a negative feedback 
loop, inhibits autoreactive T cell proliferation.
Immature mDCs activate autoreactive CCR6+ T cells efficiently
The extent of the CCR6+ autoreactive T cell proliferation 
with different subsets of autologous APCs was associated with 
the well-established capacities of these APC subsets to acti-
vate CD4+ T cells. Thus, autoreactive proliferation was highest 
with mDCs, lower with plasmacytoid DCs (pDCs), and very 
low or absent with monocytes (unpublished data). Surpris-
ingly, however, mDCs were less stimulatory for autoreactive 
T cells after LPS-induced maturation, although mature mDCs 
more potently activated allogenic T cells, as expected (Fig. 4 a). 
Interestingly, the reduced capacity of mDCs to activate au-
tologous T cells upon LPS maturation was associated with the 
down-regulation of the transcription factor AIRE (Fig. 4 b). 
Previous work has shown that AIRE allows presentation of 
tissue-restricted antigens by specialized APC subsets predom-
inantly in the thymus (Kyewski and Klein, 2006) but also in 
  effect (not depicted). CCR6+ memory T cell proliferation 
with autologous DCs shared several features with conven-
tional antigenic proliferation, as it was inhibited by neutraliz-
ing  antibodies  to  MHC  class  II  and  by  natural  T  reg  cells 
(unpublished data). CD25+ T reg cells could also proliferate with 
autologous DCs but required the addition of exogenous IL-2, 
whereas IL-10 neutralization had no effect (unpublished data).
To understand whether DCs or T cells produced the 
suppressive IL-10 in autologous cultures, we resorted the 
two  cell  types  after  co-culture  and  measured  the  IL-10 
mRNA. Notably, CCR6+ T cells constitutively expressed   
IL-10 mRNA, and IL-10 was superinduced in CCR6+ T cells   
upon  co-culture  with  DCs  (Fig.  3  b).  Conversely,  IL-10 
mRNA was neither detected in myeloid DCs (mDCs) ex 
vivo nor induced after co-culture with CCR6+ T cells, 
showing that the suppressive IL-10 was derived exclusively 
from CCR6+ T cells. Consistent with the mRNA expres-
sion, supernatants from autologous CCR6+ T cell–DC co-
cultures contained considerable amounts of IL-10 but little 
IL-2 (Fig. 3 c), consistent with the notion that autologous 
DCs provide only weak stimulation for autologous T cells in 
the absence of exogenous antigens. Conversely, both IL-10 
and IL-2 were detected in allogenic co-cultures. Notably, 
  although comparable amounts of IL-10 were produced in 
autologous and allogenic cultures, IL-10 neutralization had 
no clear effect on alloreactive T cell proliferation (Fig. 3 a). 
Thus, the capacity of CCR6+ T cells to suppress T cell 
Figure 4.  Immature mDCs most efficiently induce autoreactive T cell proliferation. (a) Purified, CFSE-labeled CCR6+ memory T cells were cultured 
with autologous or allogenic immature or LPS-matured mDCs in the presence of neutralizing anti–IL-10 antibodies, and proliferation was assessed on  
day 7. One experiment out of three is shown. (b) AIRE mRNA expression in purified monocytes, or immature or LPS-matured mDCs was measured by 
quantitative RT-PCR and normalized on 18S rRNA. AIRE expression in immature mDCs was set to 100%. The mean of three independent experiments is 
shown. (c) Purified blood monocytes, pDCs, and mDCs were stained for CCR6 surface expression in three healthy donors. Numbers indicate percentages.JEM VOL. 207, March 15, 2010 
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located close to CD11c+ DCs (Fig. 5, inset, IL-10 CD11c). 
A considerable fraction of the IL-10+ T cells coexpressed 
CCR6 (Fig. 5, bottom right, yellow), but they were largely 
negative for FOXP3 (inset, FOXP3 IL-10; and Table I). 
These results are consistent with the view that immature 
mDCs activate autoreactive CCR6+ memory T cells in the 
steady state to produce IL-10.
Context-dependent cytokine profile of CCR6+  
tetanus-specific T cell clones
We  next  analyzed  specificities  of  CCR6+  and  CCR6 
  memory T cell populations to self- and recall antigens (Fig. 6 a). 
Responses to the melanocyte self-antigen MelanA were 
  detected exclusively among CCR6+ T cells in six out of eight 
donors, whereas one donor did not respond and another one 
with a very high response among CCR6+ cells had a lower 
the periphery (Ramsey et al., 2006). Notably, human blood 
mDCs, but not pDCs or monocytes, expressed CCR6 ex 
vivo (Fig. 4 c), and they down-regulated CCR6 upon matu-
ration with LPS (not depicted). In summary, immature mDCs 
that express CCR6 and AIRE activate autoreactive CCR6+ 
memory T cells most efficiently.
To understand whether CCR6+ T cells could be acti-
vated by immature mDCs in vivo, we analyzed normal 
  human spleen sections for localization of CCR6+ T cells 
and mDCs. As shown in Fig. 5, CCR6+ T cells (yellow ar-
rows) were present in T cell zones of the human spleen, and 
the majority of them were in close proximity to CD11c+ 
DCs, i.e., mDCs (inset, CCR6 CD11c; and Table I). Strik-
ingly, we could identify IL-10–producing T cells in the hu-
man  spleen  in  situ.  Scattered  IL-10+  cells  were  detected 
within the periarteriolar T cell areas, and these cells were also   
Figure 5.  CCR6+ T cells colocalize with CD11c+ DCs and produce IL-10 in the human spleen. (top) Spleen sections showing anti-CCR6–labeled 
CCR6+ cells (red) in the anti-CD3–stained (green) T cell areas and B cell follicles with a proportion of CCR6/CD3 double-positive cells (arrows). (bottom 
left) Double immunohistochemical staining displays the distribution of CD11c+ DCs (red) predominantly in the periarteriolar CD3+ (brown) T cell areas (T) 
but also in the red pulp (RP) and the marginal zone (MZ) of the B cell follicles (B). CCR6+ cells (red) in the T cell areas are often found close to CD11c+ DCs 
(brown; inset, CCR6 CD11c). (middle right) Within the periarteriolar T cell area, scattered IL-10+ cells (brown) can be identified, and costaining with anti-
CD11c (red) indicates that some are in close contact to DCs (inset, IL-10 CD11c), whereas the large majority of IL-10+ cells were negative for FOXP3 (red, 
nuclear; inset, FOXP3 IL-10). (bottom right) Immunofluorescence shows that proportions of CD3+ or CCR6+ cells (green) coexpress IL-10 (red), resulting in 
a yellow overlay (merge). Stainings are representative of five samples each, and the cell numbers are summarized in Table I. Bars: (top; and bottom left) 
100 µm; (middle right) 50 µm; (bottom right) 10 µm.572 Context-dependent memory T cells | Rivino et al.
  stimulation at higher anti-CD3 concentration (>4 ng/ml). 
We conclude that autoreactive CCR6+ memory T cells have 
a context-dependent behavior, because cells derived from 
the  same  memory  precursor  proliferate  and  secrete  IL-2, 
IFN-, and IL-10 upon strong stimulation with recall an-
tigens, whereas they produce mainly IL-10 upon weak stim-
ulation with autologous DCs.
DISCUSSION
The presence of IL-10–producing memory cells in humans 
has been known for a long time, but their function and phe-
notype has remained unclear. In this study, we showed that 
human CCR6+ memory T cells secrete IL-10 efficiently in 
response  to  suboptimal  TCR  stimulation,  whereas  they   
produce immunostimulatory cytokines at higher levels of 
stimulation. These different activation thresholds allow auto-
reactive CCR6+ memory T cells to secrete suppressive IL-10   
in response to autologous DCs, whereas they produce IFN-, 
IL-2, and CD40L upon strong activation, as can be provided 
by a recall antigen. Thus, memory T cells that cross react   
with antigens presented by autologous mDCs could have a 
context-dependent function and inhibit autoreactivity in   
the steady state, but contribute to recall responses upon   
infections or vaccinations.
IL-10 production by T cells inhibits autoimmunity and 
immunopathology,  and  the  induction  of  IL-10–producing 
capacities in mouse Th cells requires TGF- (Maynard et al., 
2007). We found that tolerogenic priming with TGF- 
  induced CCR6 on naive T cells in vitro and that the polariz-
ing cytokines IL-12 and in particular IL-4 inhibited CCR6 
  expression. CCR6 was also induced by proinflammatory 
  cytokines and is expressed on human blood Th17 cells 
(Acosta-Rodriguez et al., 2007), raising the question of 
whether the IL-10–producing CCR6+ memory cells might 
belong to the Th17 lineage. However, we recently showed 
that IL-17 and IL-10 coproducing cells in human blood are 
largely absent from the memory compartment (Häringer et al., 
response among CCR6 cells, confirming that autoreactive 
T cells express CCR6 in healthy subjects (14 vs. 3% prolifer-
ating cells; P < 0.05; Fig. 6 b). Conversely, in four vitiligo 
autoimmune patients that have lost tolerance to melanocyte-
  derived  antigens,  MelanA-specific  cells  were  mostly  or 
  exclusively CCR6 (2 vs. 14%; Fig. 6 b). Consistent with 
previous results, tetanus-specific cells were detectable in both 
CCR6+ and CCR6 populations (Acosta-Rodriguez et al., 
2007). We next investigated whether autoreactive and recall-
specific T cells exclusively represented two distinct popula-
tions within CCR6+ T cells, or if CCR6+ T cells contained 
recall antigen–specific cells that cross reacted with antigens 
presented by autologous DCs. CCR6+ T cells that had 
  divided extensively with autologous DCs in the presence of 
anti–IL-10 were isolated and analyzed for responsiveness to 
recall antigens. A variable fraction of these autoreactive cells 
in all donors analyzed responded to various recall antigens, 
including tetanus toxoid (TT) and other nonpersistent vacci-
nation antigens (Fig. 6 c and Table II). Clones derived from 
single autoreactive cells were then analyzed for proliferation 
and cytokine production after stimulation with autologous 
APCs in the absence or presence of TT. Several autoreactive 
CCR6+ clones from two different donors were obtained that 
proliferated vigorously with TT and produced high amounts 
of IL-2, IL-10, and IFN- (Fig. 7, a and b), but not IL-17 
(not depicted). Notably, when cells from the same tetanus-
specific clones were stimulated with autologous mDCs alone, 
they produced IL-10 but not IL-2 and proliferated poorly 
and only upon IL-10 neutralization (Fig. 7 b). Conversely, 
two CCR6 tetanus-specific clones from the same donors 
did not respond to mDCs alone (Fig. 7, a and b). Finally, 
  autoreactive, tetanus-specific CCR6+ T cell clones had dif-
ferent activation thresholds for IL-2 and IL-10 production, 
as expected. Thus, they produced IL-10 only with anti-CD3 
alone (unpublished data) or after CD28 co-stimulation at low 
anti-CD3 concentrations (1–2 ng/ml; Fig. 7 c). Conversely, 
they produced IL-2 together with IL-10 after CD28 co-
Table I.  Number of T cells interacting with mDCs, expressing CCR6, FOXP3, or IL-10 in human spleen sections
T cell area Total CD3+ CD3+ close to 
DCs
Total CCR6+ CCR6+ close  
to DCs
Total FOXP3+ CD3+ IL-10+ FOXP3+ IL-10+ CCR6+ IL-10+
1A 137 42 21 14 5 13 1 4
1B 124 38 17 12 4 11 0 2
2A 175 61 35 23 12 15 1 5
2B 225 95 63 37 8 22 2 7
3A 105 31 14 11 3 8 0 3
3B 92 28 9 7 4 9 0 1
4A 80 26 7 6 3 7 0 2
4B 76 20 7 5 5 5 0 3
5A 119 42 13 9 6 11 0 2
5B 85 31 10 4 3 6 0 1
Mean 122 ± 47 41 ± 22 20 ± 17 13 ± 10 5 ± 3 11 ± 5 0.4 ± 0.7 3 ± 2
% 34 (CD3+) 16 (CD3+) 66 (CCR6+) 4 (CD3+) 9 (CD3+) 4 (IL-10+) 28 (IL-10+)
Cells staining positive for CD3, CCR6, IL-10, or FOXP3 in the vicinity or not of CD11c mDCs were counted in two T cell areas (A and B) in five different spleen samples (1–5), 
and the mean numbers, percentages, and standard deviations were calculated.JEM VOL. 207, March 15, 2010 
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in  the  vicinity  of  CCR6+  mDCs.  Obviously,  we  cannot 
  exclude that chemokines other than CCL20 are responsible 
for this colocalization; in particular, CCR4 ligands are known 
to be constitutively expressed by immature mDCs, and a 
  fraction  of  IL-10–producing  CCR6+  T  cells  coexpresses 
CCR4 (unpublished data). Importantly, we could show that 
some of the CCR6+ T cells in the spleen were actively secre-
ting IL-10 and interacted with mDCs, but were mostly 
FOXP3. Mouse T cells with IL-10–producing capacities 
have been previously detected at low frequency in the spleen 
of mice and are enriched in the gut (Maynard et al., 2007). In 
humans,  IL-10–producing  T  cells  have  been  previously 
  visualized in the gut (Uhlig et al., 2006), but to our knowl-
edge this is the first study that characterizes IL-10–producing 
T cells in the human spleen in situ. Collectively, the in situ 
findings are consistent with the view that autoreactive CCR6+ 
memory T cells are activated by mDCs to secrete IL-10 under 
steady-state  conditions.  Moreover,  autologous  immature 
mDCs specifically activated CCR6+ memory T cells to 
  produce suppressive IL-10 ex vivo. These circulating mDCs 
were isolated ex vivo, because in contrast to in vitro–generated 
DCs, they present physiologically relevant self- and innoc-
uous foreign antigens. Immature mDCs expressed AIRE 
and down-regulated this transcription factor upon matura-
tion with LPS, consistent with the view that immature DCs 
are tolerogenic and might be able to present tissue-restricted 
self-antigens  (Steinman  and  Nussenzweig,  2002;  Kyewski 
and Klein, 2006). Consistently, in some donors the T cells 
that had proliferated upon contact with immature mDCs 
  responded to the self-antigen MelanA, which is also ex-
pressed in AIRE+ medullary thymic epithelial cells. It should 
be noted that the peptides that activate CCR6+ T cells in the 
steady state are not necessarily derived from self-antigens 
but might also be derived from innocuous foreign antigens to 
which normal individuals are continuously exposed. Finally, 
inhibitory cytokines secreted upon DC maturation could also 
  reduce the proliferation of autologous T cells.
CCR6+ memory T cells were IL-7R+ and possessed 
both IL-2– and IL-10–producing capacities, and are thus dif-
ferent from previously described professional T reg cell sub-
sets (Groux et al., 1997; Sakaguchi, 2004; Vieira et al., 2004; 
2009).  Moreover,  the  autoreactive,  tetanus-specific  clones 
analyzed did not produce IL-17, consistent with the view that 
IL-10–producing  CCR6+  memory  cells  are  distinct  from 
Th17 cells. Nevertheless, a considerable fraction of IL-10– 
producing  CCR6+  memory  T  cells  possessed  CCL20- 
producing capacities and could thus attract other CCR6+  
cells, including immature mDCs (Vanbervliet et al., 2002).   
Although CCL20 production was low in response to weak 
TCR stimulation, these low amounts might be nevertheless 
physiologically relevant. Consistently, in situ analysis revealed 
that CCR6+ T cells in normal human spleens were enriched 
Figure 6.  CCR6+ T cells respond to self- and recall antigens in 
healthy donors. (a) Sorted CFSE-labeled CCR6+ and CCR6 T cells from 
healthy individuals were cultured with autologous monocytes with or 
without MelanA or TT. CFSE profiles of CD3+CD14 cells were analyzed on 
day 7 by flow cytometry. One representative donor out of eight analyzed 
in independent experiments is shown. (b) Percentage of proliferating  
(CFSElo) CCR6+ and CCR6 T cells in eight healthy donors and six vitiligo 
patients. Horizontal bars indicate the mean percentages. (c) Autoreactive 
T cell lines were generated by stimulating CCR6+ T cells with autologous 
mDCs plus anti–IL-10 and sorting of cells that had lost CFSE on day 7. 
Cells were then incubated with autologous monocytes with or without 
MelanA, TT, or other recall antigens for 24 h in the presence of brefeldin 
A, and intracellular staining of cytokines was detected with specific  
antibodies (Table II). Forward scatter (FSC) and staining for IL-2 of autore-
active cells of one donor are shown. Numbers indicate percentages.
Table II.  Antigen specificities of autoreactive T cell lines
TT PPD Flu MelanA
Donor 1 + n.d. + n.d.
Donor 2  ++ ++ ++
Donor 3 ++ n.d. + +
Donor 4 + + + 
Donor 5 n.d. n.d. + n.d.
CCR6+ T cells that had completely lost CFSE labeling after stimulation with 
autologous DCs and anti–IL-10 antibodies for 7 d were sorted, expanded with 
recombinant IL-2, and tested for cytokine production (TNF, IFN-, or IL-2) after 
restimulation with autologous monocytes in the absence or presence of TT, purified 
protein derivate (PPD), influenza hemagglutinin (Flu), or MelanA. , cytokine 
responses <0.1% over control; +, cytokine responses between 0.1 and 1% over 
control; and ++, cytokine responses >1% over control. n.d., not done.574 Context-dependent memory T cells | Rivino et al.
lular heterogeneity, but single memory cells have the potential 
to secrete different cytokines depending on the conditions 
of antigenic stimulation and thus exert different functions. It 
should be noted that the autoreactive memory clones we iso-
lated  are  distinct  from  conventional  autoreactive  T  cell 
clones that are fully activated by autologous APCs alone 
(Kitani et al., 2000), but they might be related to the ones 
that spontaneously grow out from PBMCs and react with 
multiple self-antigens (Cai and Hafler, 2007).
Our data raise the question of why the immune system 
harbors context-dependent regulatory memory T cells when 
it already possesses different types of professional T reg cells. 
In  the  thymus  and  the  periphery,  T  cells  are  selected   
to  recognize  self-antigens  with  low  affinity,  and  highly   
autoreactive naive T cells that escape negative selection 
are probably immediately deleted or converted to profes-
sional T reg cell cells in the periphery. Conversely, many 
slightly autoreactive T cells that are not sufficiently activated 
by immature DCs in the naive state might be suboptimally   
activated  after  differentiation  to  memory  cells,  because 
memory  cells  are  characterized  by  a  lower  activation 
threshold (Pihlgren et al., 1996). In this scenario, newly 
generated memory T cells that are activated by immature 
Scheffold et al., 2005; Häringer et al., 2009). It was previously 
reported that IL-2 and IL-10 are differentially regulated by 
the co-stimulatory receptors inducible T cell co-stimulator, 
CD28, and CD40L (Hutloff et al., 1999; Blair et al., 2000). 
We found that in human memory T cells, IL-10 was efficiently 
induced by low-level stimulation with anti-CD3 in the ab-
sence of CD28 co-stimulation. We believe that IL-10 produc-
tion in response to suboptimal stimulation is physiologically 
relevant, because mDCs, which are poorly stimulatory for 
autologous T cells in the absence of foreign antigens as a 
consequence of thymic selection, induced IL-10 quite effi-
ciently. Conversely, secretion of IFN- and especially of IL-2 
as well as expression of CD40L required strong activation 
that could be provided with anti-CD3/CD28 co-stimulation 
or allogenic DCs. Importantly, we found that different acti-
vation thresholds for IL-10 and IL-2 were also present in clones 
derived from single autoreactive CCR6+ memory T cells. In 
particular,  different  cytokine  profiles  and  proliferative  re-
sponses were induced in these clones with antigens associated 
with steady-state conditions (i.e., ex vivo–isolated mDCs) 
and recall responses (i.e., TT). Thus, the different cytokine 
profiles detected after weak or strong stimulation of poly-
clonal memory T cell populations do not simply reflect cel-
Figure 7.  Autoreactive CCR6+ T cell clones produce IL-2 with recall antigens. Clones were generated by expanding single cells from CCR6+ auto-
reactive T cell lines or from CCR6 TT-specific control lines and screened for tetanus specificity by [3H]thymidine incorporation after stimulation with TT.  
(a) Culture supernatants of TT-specific clones were assessed for the presence of IL-2, IFN-, and IL-10 by ELISA. Shown are concentrations of IL-10, IFN-, 
and IL-2 produced by three different autoreactive CCR6+ clones (gray bars, A–C) and two different CCR6 control clones (black bars, D and E) derived from 
the same two donors. (b) Proliferation measured by [3H]thymidine incorporation of CCR6+ (A and B) and CCR6 (E) TT-specific clones derived from the same 
donor in response to autologous monocytes (left) in the absence (open bars) or presence (shaded bars) of TT, and to autologous mDCs (right) with (shaded 
bars) or without (open bars) IL-10 neutralization. (c) Production of IL-2 (black lines) and IL-10 (red lines) of the same two CCR6+ TT-specific T cell clones  
(A and B; continuous and dotted lines, respectively) in response to different concentrations of anti-CD3 antibodies in the presence of CD28 co-stimulation.JEM VOL. 207, March 15, 2010 
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mRNA extraction and quantitative RT-PCR. IL-10 and AIRE mRNA 
induction was analyzed by real-time quantitative RT-PCR. After co-
  culture, DCs and T cells were reseparated by cell sorting and total RNA was 
extracted using the TRIzol method (Invitrogen) according to the manufac-
turer’s instructions. cDNA synthesis was performed by RT-PCR by using 
random hexamers and a Moloney murine leukemia virus transcriptase kit 
(Agilent Technologies). IL-10 transcripts were quantified by real-time quan-
titative PCR on a sequence detector (ABI PRISM 7700; Applied Biosys-
tems)  with  predesigned  gene  expression  assays  and  reagents  (TaqMan; 
Applied Biosystems). For each sample, the mRNA abundance was nor-
malized to the amount of 18S rRNA and is expressed in arbitrary units.
Immunohistochemistry. 2–3-µm-thick sections of formalin-fixed, paraffin-
embedded tissue from well-preserved splenectomy specimens after trauma 
were cut, deparaffinized, and subjected to a heat-induced epitope retrieval 
step. Slides were rinsed in cool running water and washed in Tris-buffered 
saline,  pH  7.4,  before  incubation  with  primary  rabbit  anti-CD3  (clone 
N1580; 1:10; Dako), mouse anti-CD3 (clone LN10; 1:100; Novocastra), 
mouse anti-CCR6 (clone 53103; 1:20; R&D Systems), mouse anti-CD11c 
(clone 5D11; 1:20; Novocastra), rabbit anti–IL-10 (clone 500-P20; 1:100; 
PeproTech), or rat anti-FOXP3 (clone PCH101; 1:100; eBioscience) anti-
bodies for 30 min. For detection, donkey anti–rabbit (Dianova), rabbit 
anti–rat (Dako), or donkey anti–mouse (Dianova) secondary antibodies were 
used,  followed  by  the  streptavidinPO  kit  (Dako),  the  streptavidinAP  kit 
(Dako), the EnvisionPO kit (Dako), or the alkaline phosphatase anti–alkaline 
phosphatase  method.  Alkaline  phosphatase  was  revealed  by  Fast  Red  as 
chromogen, and peroxidase was developed with a highly sensitive diami-
nobenzidine chromogenic substrate for 10 min. Negative controls were per-
formed  by  omitting  the  primary  antibodies.  For  anti–IL-10  labeling, 
EBV-positive  classical  Hodgkin  lymphoma  served  as  a  positive  control 
(Herbst et al., 1996). Additional negative controls were performed by block-
ing the IL-10 antibody with recombinant human IL-10 (Sigma-Aldrich). For 
double immunofluorescence labeling, sections were incubated with rabbit 
anti-CD3 or mouse anti-CCR6 antibody followed by Alexa Fluor 488–
  conjugated anti–rabbit or anti–mouse antibody (1:100; Invitrogen), washed 
three times in PBS, and incubated with mouse anti-CCR6 or rabbit anti–IL-10 
followed by Alexa Fluor 555–conjugated anti–mouse or anti–rabbit antibody 
(1:100;  Invitrogen).  Nuclei  were  counterstained  with  DAPI  (1:1,500; 
Roche), and slides were mounted in Fluoromount-G (SouthernBiotech). 
Images  were  acquired  using  a  fluorescence  microscope  (AxioImager  Z1) 
equipped  with  a  charge-coupled  device  camera  (AxioCam  MRm)  and 
  processed with AxioVision software (all purchased from Carl Zeiss, Inc.).
Statistics. Statistical significance was calculated with a two-tailed Student’s 
t test. P < 0.05 was regarded as statistically significant.
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